Guidance
Evidence-based recommendations on botulinum toxin type A injections into the urethral sphincter for idiopathic chronic non-obstructive urinary retention. This involves injecting botulinum toxin type A into the urethral sphincter.
Is this guidance up to date?
Next review: 2026
Guidance development process
How we develop NICE interventional procedures guidance
Coding and clinical classification codes for this guidance.